secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cryoport, Inc. (CYRX)
CIK:        0001124524
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001558370-25-008613
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cryoport completes CRYOPDP divestiture to DHL for ~$200M in cash; launches strategic partnership
--------------------------------------------------------------------------------

- Total cash consideration of ~$200M: $133M purchase price plus repayment of $77.2M in intercompany loans.
- Strategic partnership with DHL Group to collaborate on life sciences supply chain, expanding APAC and EMEA reach.
- Pro forma net loss from continuing ops improves: Q1 2025 loss $7.3M vs. $9.0M reported; FY2024 loss $104.5M vs. $114.8M.
- Company says deal provides capital to focus on advancing Life Science Services platform and Regenerative Medicine market.
- Divested entity represented $71.6M revenue in FY2024; proceeds bolster cash to $246.3M pro forma as of March 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124524/000155837025008613/0001558370-25-008613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124524/000155837025008613/cyrx-20250611x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer